Acute eosinophilic pneumonia (AEP) is characterized by a febrile illness, diffuse pulmonary infiltrates, hypoxemic respiratory failure, and pulmonary eosinophilia. A temporal relationship has been described in a number of patients between the development of AEP and the recent onset of cigarette smoking. A 22-year-old male patient with no known chronic disease was admitted to the emergency service for 3 days with the complaints of cough, fever, dyspnea, and pleuritic chest pain. He was formerly a nonsmoker but was a waterpipe (narghile, hookah) tobacco smoker as a new habit once a night for the last 2 months. The erythrocyte sedimentation rate and C-reactive protein are elevated. Arterial blood gases revealed moderate hypoxemia. Computed tomography scans included bilateral, random, and patchy ground-glass opacities and also small bilateral pleural effusions. Echocardiograhic examination was normal. We had accepted the patient as an acute eosinophilic pneumonia due to rapid response to corticosteroid treatment, no microorganism in bronchoalveolar lavage (BAL) culture, and predominant eosinophilia was observed (70%-80%) in BAL.
Introduction
A cute eosinophilic pneumonia (AEP) was first described as a cause of acute respiratory failure in 1989. AEP is characterized by a febrile illness, diffuse pulmonary infiltrates, hypoxemic respiratory failure, and pulmonary eosinophilia. The mechanism of AEP remains unknown. Some investigators have suggested that AEP is an acute hypersensitivity reaction to an unidentified inhaled antigen in an otherwise healthy individual. [1, 2] A temporal relationship has been described in a number of patients between the development of AEP and the recent onset of cigarette smoking either the first time or following a period of smoking cessation and also waterpipe tobacco smoking (WPS). [3] [4] [5] [6] [7] [8] [9] [10] Although the underlying mechanisms of WPS leading to AEP are not well understood, case reports and case series suggest a strong correlation between recent cigarette smoking or alteration in smoking habits and development of AEP. [7] We reported the case with AEP following recent onset of WPS.
Case Report
A 22-year-old male patient with no known chronic disease was admitted to the emergency service for 3 days with the complaints of cough, fever, dyspnea, malaise, myalgias, and pleuritic chest pain. He was formerly a nonsmoker but was a waterpipe (narghile, hookah) tobacco smoker as a new habit once a night for the last 2 months. Physical examination This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com been described in a number of patients between the development of AEP and the recent onset of cigarette smoking. [3] [4] [5] WPS called narghile in Turkish has becoming widespread worldwide and is also one of the most popular and epidemic forms of tobacco use among Turkish youth. [12] Narghile is a preparation of tobacco, glycerol, and other additives and flavors using charcoal separated by thin aluminum foil to heat the mixture. Air drawn in over the charcoal passing through the tobacco mixture through the waterpipe before the vapors cool are released as a dense aerosol produces the smoke. Hookah smoking, compared with cigarette smoking, produces a greater content of tobacco smoke, tar, carbon monoxide, polyaromatic hydrocarbons, and carbonylic compounds. [7] Possible mechanisms of respiratory diseases in WPS were explored in in vitro and in vivo studies. WPS resulted in increased airway resistance, lung inflammation, oxidative stress, and catalase activity in animal lungs. [13] In humans, levels of inflammatory cytokines were decreased in the exhaled breath of WP smokers, while the bronchoalveolar lavage fluid of WPS with chronic obstructive pulmonary disease (COPD) had increased metalloproteinase two and nine gene expression similar to that of cigarette smokers with COPD. [14] The diagnosis of AEP can usually be made in patients who meet the following clinical criteria including a febrile illness of short duration (often <1 week), hypoxemic respiratory failure, diffuse pulmonary infiltrates on chest radiograph, BAL differential cell count showing eosinophilia >25% with exclusion of known causes of pulmonary eosinophilia plus recent alterations in smoking habits, and the absence of infection or alternative causes for eosinophilia. BAL with differential cell count should be performed early if the etiology is in question. [2, 3, 10, 15] We had accepted the patient as AEP based on typical clinical criteria above and also due to rapid clinical and radiological response revealed fever (38.5ºC), tachypnea, and desaturation with pulse oximetry. Bibasilar inspiratory crackles are heard on auscultation of the chest. The patient was presented with an initial neutrophilic leukocytosis (white blood cell: 17.000, eosinophil 1.9%). The erythrocyte sedimentation rate (12 mm/h) and C-reactive protein (2.02 mg/dL) were elevated. Arterial blood gases revealed moderate hypoxemia. Posterior-anterior chest film showed bilateral pulmonary infiltrates with bilateral blunted costodiaphragmatic angle [ Figure 1a ]. High-resolution computed tomography scans included bilateral, random, and patchy ground-glass opacities and also small bilateral pleural effusions [ Figure 2 ]. To both diagnose AEPs and to rule out possible infectious and cardiac etiology, fiberoptic bronchoscopy for bronchoalveolar lavage (BAL) and echocardiography was performed. Echocardiograhic examination was normal. On BAL corticosteroid therapy (0.5 mg/kg) and nonspecific antibiotics were initiated. The parenchymal infiltration except bilateral mild pleural effusion was almost resolved radiographically following 2 days of treatment [ Figure 1b] and was completely resolved after 2 weeks of treatment [ Figure 1c ]. We had accepted the patient as AEP due to rapid response to corticosteroid treatment, no any microorganism in BAL culture and predominant eosinophilia (lymphocyte 5%, macrophage 7%-8%, eosinophil 70%-80%, epithelial 1%-2%, and PNL 7%-8%) in BAL [ Figure 3a -c]. Corticosteroid therapy has been continued for 2 months after THE initiation of therapy.
Discussion
AEP can be caused by drugs, toxins, infections, smoking, and lung irradiation; these possibilities are best investigated by a careful history. [11] Recent alterations in smoking habits, not only beginning to smoke but also restarting to smoke and increasing daily smoking doses, are associated with the development of AEP. AEP has been associated most often with new onset or resumption of cigarette smoking. A temporal relationship has 
Conclusion
As tobacco initiation or increase in amount is often associated with AEP and as relapses have been associated with resumption of smoking, complete smoking cessation should be strongly encouraged. AEP should be considered as a possible diagnosis in patients with unexplained acute febrile respiratory failure and pulmonary infiltrates after recent exposure to recent inhaled hookah smoking.
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to corticosteroid treatment, the delayed response to pleural effusion. The pleural effusion has resolved more slowly than the pulmonary parenchymal infiltrates in the present case which is compatible with the literature. [16] Written informed consent was obtained from a patient who participated in this study. 
